[HTML][HTML] Advances in nanostructures for antimicrobial therapy
J Jampilek, K Kralova - Materials, 2022 - mdpi.com
Microbial infections caused by a variety of drug-resistant microorganisms are more common,
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
Advances in Nanostructures for Antimicrobial Therapy
J Jampilek, K Kralova - Materials, 2022 - ui.adsabs.harvard.edu
Microbial infections caused by a variety of drug-resistant microorganisms are more common,
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
Advances in Nanostructures for Antimicrobial Therapy
J Jampilek, K Kralova - Materials (Basel, Switzerland), 2022 - pubmed.ncbi.nlm.nih.gov
Microbial infections caused by a variety of drug-resistant microorganisms are more common,
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
Advances in Nanostructures for Antimicrobial Therapy.
J Jampilek, K Kralova - Materials (Basel, Switzerland), 2022 - europepmc.org
Microbial infections caused by a variety of drug-resistant microorganisms are more common,
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
[PDF][PDF] Advances in Nanostructures for Antimicrobial Therapy
J Jampilek, K Kralova - J. Orthop. Res, 2018 - researchgate.net
Microbial infections caused by a variety of drug-resistant microorganisms are more common,
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
[PDF][PDF] Advances in Nanostructures for Antimicrobial Therapy
J Jampilek, K Kralova - J. Orthop. Res, 2018 - academia.edu
Microbial infections caused by a variety of drug-resistant microorganisms are more common,
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
Advances in Nanostructures for Antimicrobial Therapy
J Jampilek, K Kralova - Materials, 2022 - search.proquest.com
Microbial infections caused by a variety of drug-resistant microorganisms are more common,
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
[HTML][HTML] Advances in Nanostructures for Antimicrobial Therapy
J Jampilek, K Kralova - Materials, 2022 - ncbi.nlm.nih.gov
Microbial infections caused by a variety of drug-resistant microorganisms are more common,
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
Advances in Nanostructures for Antimicrobial Therapy.
J Jampilek, K Kralova - Materials (1996-1944), 2022 - search.ebscohost.com
Microbial infections caused by a variety of drug-resistant microorganisms are more common,
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
Advances in Nanostructures for Antimicrobial Therapy.
J Jampilek, K Kralova - Materials (Basel, Switzerland), 2022 - europepmc.org
Microbial infections caused by a variety of drug-resistant microorganisms are more common,
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …
but there are fewer and fewer approved new antimicrobial chemotherapeutics for systemic …